DRMA
Dermata Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:31:01 PM EST
0.56USD-2.122%(-0.01)1,798
Pre-marketNov 19, 2026 8:52:30 AM EST
0.5463USD+1.148%(+0.0062)
After-hoursNov 18, 2026 4:00:30 PM EST
0.5401USD-3.208%(-0.0179)
DRMA Financials
In Q3 FY 2026 (ended ), Dermata Therapeutics, Inc. Common Stock (DRMA) reported revenue of $74.14K, net income of −$2.82M, operating cash flow of −$2.65M, and assets of $6.64M (filed ).
Loading financial statements…